期刊文献+

瑞士乳杆菌发酵制备牦牛乳酪蛋白源性降血压肽的工艺研究 被引量:1

The Studies on the Preparation of Antihypertensive Peptides of Yak Milk Casein Fermentation with Lactobacillus Helveticus
下载PDF
导出
摘要 目的:以牦牛乳源酪蛋白为原料,利用瑞士乳杆菌,对发酵法制备降血压肽的工艺进行初步探讨.方法:试验首先采用凝乳酶沉淀法从牦牛乳中提取酪蛋白,依据瑞士乳杆菌的发酵特点,按5%(体积比)接菌量进行发酵制备降血压肽.然后并以降血压肽对血管紧张素转换酶(ACE)的抑制率为指标,主要探讨了底物浓度、pH值、发酵时间三因素对瑞士乳杆菌发酵法制备降血压肽工艺的影响.结果:在接菌量为5%,其他三因素各设置五个水平进行工艺优化,最优工艺条件为:底物浓度4%、发酵pH值8.0、发酵时间16 h.此工艺条件下ACE抑制率可达约68%.结论:通过实验说明底物浓度、pH值、发酵时间等参数的控制对发酵酪蛋白制备抑制肽很重要,此试验数据为后续进一步完善制备降血压肽的实验奠定了重要的基础. Objective: Yak Casein and Lactobacillus helveticus as raw material, the preparation process of antihypertensive peptides using fermentation method was discussed. Methods: Firstly we extracted casein from yak milk using rennet precipitation method, and preparated antihypertensive peptides of fermentation using 5 % (volume ratio) inoculation amount according to the fermentation characteristics of Lactobacillus helveticus.Then inhibitory rate of antihypertensive peptides to angiotensin- converting enzyme ACE) as indicators, we mainly discussed the influence of the substrate concentration, pH value, the fermentation time to antihypertensive peptides preparation of fermentation method. Results: While the inoculums was 5 %, other three factors of each set five levels to process optimization, the optimum conditions as follows: substrate concentration was 4 % pH value of fermentation was 8.0, the fermentation time was 16h. The ACE inhibition rate was almost to 68 % in this condition. Conclusion: the control of substrate concentration, pH value, the time of fermentation and other parameters are very important to preparation of antihypertensive peptides. This experimental test data laid an important foundation for further preparation of antihypertensive peptides more efficiently.
出处 《西北民族大学学报(自然科学版)》 2013年第2期64-71,共8页 Journal of Northwest Minzu University(Natural Science)
基金 甘肃省农业生物技术研究与应用开发项目<牦牛乳源降血压肽和水解乳蛋白制备工艺技术研究与开发>(GNSW-2011-17) 校地合作项目<牦牛乳的综合开发与利用>(XBMU-2011-BC-42) 甘肃省科技支撑计划项目<水解乳蛋白的制备及产业化>(2010-147号)
关键词 瑞士乳杆菌 降血压肽 血管紧张素转化酶(ACE) ACE抑制肽 Lactobacillus helveticus Antihypertensive peptides Angiotensin - converting enzyme (ACE) ACE inhibitory peptides
  • 相关文献

参考文献12

  • 1Arai S, Osawa T, Ohigashi H. A mainstay of funcitional food Science in Japan - history, Present Status and Future Outlook [ J ]. Biosei Biotechnol Biochem, 2001,65:1 - 13.
  • 2Anne Pihlanto- Leppa la. Bioactive peptides derived from bovine whey proteins: opioidan- dace- inhibitory peptides[J].Trends in Food Science and Technology, 2001,11:347- 356.
  • 3史云丽,刘芳,潘曼,刘建军.大米生物活性肽研究进展[J].食品与机械,2009,25(2):167-171. 被引量:8
  • 4何慧,郭会侠,孔林,陈军明,隋玉杰,王进.用玉米大豆复配蛋白制备降血压肽水解酶筛选研究[J].中国粮油学报,2005,20(6):25-29. 被引量:22
  • 5Kunio Suetsuna, Jiun Rong Chen. Identification of antihypertensive peptides from peptic Digest of two microalgae, chloreUa vulgaris and spirulina platensis[J]. Marine Bioteehnol, 2001, (3) :305- 309.
  • 6于晓庆,王雄,司佳.酶法制备乳源ACE抑制肽[J].食品研究与开发,2011,32(9):134-136. 被引量:10
  • 7陆仲璘,何晓林.牦牛乳的开发利用刍议[J].中国牛业科学,2009,35(5):46-48. 被引量:14
  • 8王秋韫,庞广昌,陈庆森.牛乳酪蛋白来源的生物活性肽[J].天津商学院学报,2001,21(3):6-9. 被引量:9
  • 9Yamamoto N, Akino A, Takano T. Antihypertensive effect of the pepticles derived from casein by an extraceUuar proteinase from LactobacKlus helveticus CP790[J] .J Dairy Sci, 1994,77: 917- 922.
  • 10Maeno M, Yamamoto N, Takano T. Identification of an antihypertensive peptide from casein hydrolysate produced by a proteinase from Lactobacillus helveticus CP790[J] .J Dairy Sci, 1996, 79:1316 - 1321.

二级参考文献93

共引文献70

同被引文献16

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部